Neogen Corporation (NASDAQ:NEOG) Q2 2024 Earnings Call Transcript

Page 2 of 2

Brandon Vasquez: Okay, thanks, Dave. And maybe one last follow-up to that last comment you were making, just to be clear, we’re talking a lot of moving pieces, but many of these seem like they’ll be executed on in fiscal 2024. Is the biggest maybe uncertainty in the bridge from today to fiscal ‘25 macro, or are there other factors that we should be keeping an eye on?

Dave Naemura: I think macro is the biggest, pace of recovery, state of the macro economy. We’re going to work through the things that are within our control, but not everything is. So, we’ll take – we’ll snap the line on the environment as we exit the year.

Brandon Vasquez: Okay. Thanks guys.

Operator: The next question comes from David Westenberg with Piper Sandler. Please go ahead.

Unidentified Analyst: Hi. This is John on for Dave. Thanks for taking the question. Can you walk us through what the genomics business performance would look like aside from the loss of the customer and how we should think about that going forward?

John Adent: So, when you think about the genomics business, what’s really driving that is we made the decision that when you use, or when you service smaller animals like poultry that have a relatively low value, and those customers are under tremendous distress in their business, that the price pressure for those services got to a point where we just said, that’s not interesting to us. So, we refocused the business to really move to the higher value, which is larger animals, cattle dairy and companion animal, and that’s a big point. Quantifying what those customer losses were, I mean, I think it’s in the $3 million to $4 million range, but I don’t really have that. It’s not a – when you think about it from the total piece of the business, to me it’s not really material.

It’s really that macro environment of those poultry predominantly and some swine, but poultry predominantly is really the challenge in really finding ways that – it just got to a price point it was unsustainable for us.

Unidentified Analyst: Got it. Thank you. And can you remind us of any other second half comps that we should be aware of for our models?

Dave Naemura: I don’t think I’d call anything out in particular at this stage.

John Adent: I mean, I think the only thing John is, like we talked about with the macro environment, right, looking at the same thing we do, you know who our customer bases are, and looking at their commentary around the second half, we’re really aligned with them. And the things that I’ve seen from a number of them, they’re pretty much saying the same story with the customers, that they are value-buying and that they are seeing the market improving, but they’re still not growing. So, sequentially, they’re getting better, but it’s still not to a point where they have growth. And that’s what we’re seeing in the marketplace. So, I think that would be the thing that I would most watch is that macro environment. Dave, you’ve got anything you want to add to that?

Dave Naemura: No, I think that’s right.

Unidentified Analyst: Got it. Thank you.

Operator: This concludes our question-and-answer session. I would like to turn the conference back over to John Adent for any closing remarks.

John Adent: Thank you, Betsy. I just want to thank everybody for joining us this morning. We’re excited about the second half of the year. I want to wish all of you a fantastic 2024 and I look forward to talking to all of you again in April.

Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.

Follow Neogen Corp (NASDAQ:NEOG)

Page 2 of 2